What this story covers

West Pharmaceutical Services reported 2 point 95 billion dollars in 2023 net sales, up 2 point 2 percent, with Proprietary Products facing COVID sales drop but Contract-Manufactured growing 15 percent. Net income rose to 593 million dollars (7 dollars 88 cents EPS). Strong cash flow of 777 million dollars funded expansions and repurchases. Risks include supply chains, regulations, and currencies, mitigated by hedges. Robust liquidity with low debt supports ongoing innovation in drug delivery systems.

Story snapshot